Keywords
Functional capacity
Quality of life
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To analyze the profile of non-motor symptoms in patients with Parkinson’s disease. Methods: Cross-sectional quantitative observational study with 53 patients of both sexes and ages between 43 and 85 years, evaluated through a questionnaire on non-motor symptoms of Parkinson’s disease, including dysphagia, dysphonia, hyposmia, hypoacusis, imbalance, speech and language alterations, sleep disorders, and cognitive deficit, and through standardized scales (Hoehn and Yahr Scale and Epworth Sleepiness Scale). Results: There was a predominance of females (64.2%), with 67.9% aged ≥60 years and 94.3% literate. The mean duration of symptoms was 5.5 years, with prevalence of sleep disorders (86.8%), dysphagia (75.5%), speech disorders (66%), language alterations (41%), hypoacusis (34%), and balance alterations (36.5%), as well as nutritional and cognitive complications. Statistical analysis indicated a non-normal distribution of sleepiness and disease progression scores, with no significant correlation between motor severity and daytime sleepiness. Conclusion: Non-motor symptoms of Parkinson’s disease are prevalent, increasing disease morbidity and reducing quality of life. This knowledge is important for individualized management and rehabilitation of this population.
References
ACÁCIO BLS, et al. Perfil clínico e epidemiológico de pacientes com Doença de Parkinson atendidos em um ambulatório de neurogeriatria. Revista Brasileira de Revisão de Saúde, 2024; 1: 5915–5925.
ANANTHAVARATHAN P, et al. Neurological update: non-motor symptoms in atypical parkinsonian syndromes. Journal of Neurology, 2023; 270: 4558–4578.
BARBOSA ALG, et al. Avaliação da deglutição e o impacto na qualidade de vida em pacientes com doença de Parkinson. Revista Eletrônica Acervo Saúde, 2020; 12(4): e2929.
BARRETO KS, et al. Non-motor symptoms fluctuations in patients with Parkinson's disease at the Clinical Hospital of Salvador, Bahia. Dementia Neuropsychologia, 2022; 16(2): 213–219.
BUGALHO P, et al. Progression in Parkinson's disease: variation in motor and non-motor symptoms severity and predictors of decline in cognition, motor function, disability, and health-related quality of life as assessed by two different methods. Movement Disorders Clinical Practice, 2021; 8(6): 885–895.
CABREIRA V, MASSANO J. Doença de Parkinson: Revisão clínica e atualização. Acta Médica Portuguesa, 2019; 32(10): 661–670.
CAMICIOLI RM, et al. Neuropsychiatric symptoms and Parkinson disease. Neurology, 2023; 101(12): e207722.
CARPI M, et al. Both motor and non-motor fluctuations matter in the clinical management of patients with Parkinson's disease: an exploratory study. Journal of Personalized Medicine, 2023; 13(2): 242.
CHEN J, et al. Managing non-motor symptoms of Parkinson disease in China: a nationwide survey of neurologists and psychiatrists. BMC Neurology, 2025; 25: 168.
DI LAUDO F, et al. Daytime sleepiness in Parkinson’s disease: a multifaceted symptom. Frontiers in Sleep, 2023; 2: e1302021.
GARASTO E, et al. Association between hearing sensitivity and dopamine transporter availability in Parkinson’s disease. Brain Communications, 2023; 5(2): 1–10.
GARASTO E, et al. Hearing dysfunction heralds an increase in non-motor burden and a worse quality of life in Parkinson’s disease: new insights from non-motor spectrum. Neurological Sciences, 2024; 45: 4299–4307.
GONÇALVES MT, et al. Epworth sleepiness scale: a meta-analytic study on the internal consistency. Sleep Medicine, 2023; 109: 261–269.
GOOCH E, et al. Higher frequency of stuttered disfluencies negatively affects communicative participation in Parkinson’s disease. Journal of Speech, Language, and Hearing Research, 2024; 67(3): 3631–3642.
GUI M, et al. Vestibular dysfunction in Parkinson’s disease: a neglected topic. Frontiers in Neurology, 2024; 15: 1398764.
JANKOVIC J, TAN EK. Parkinson’s disease: Etiopathogenesis and treatment. Journal of Neurology, Neurosurgery & Psychiatry, 2020; 91(8): 795–808.
JOSE M, et al. Functional hearing impairment common in Parkinson’s disease: Insights from a pilot study. Clinical Neurology and Neurosurgery, 2024; 246: 108524.
KATAOKA H, SUGIE K. Association between fatigue and Hoehn-Yahr staging in Parkinson’s disease: eight-year follow-up study. Neurology International, 2021; 13(2): 224–231.
LAPA JDDS, et al. Burst transspinal magnetic stimulation alleviates nociceptive pain in Parkinson disease—a pilot phase II double-blind, randomized study. Neuromodulation: Technology at the Neural Interface, 2023; 26(4): 840–849.
LEONHARDT B, et al. Awareness of olfactory dysfunction in Parkinson’s disease. Neuropsychology, 2019; 33(5): 633.
LEMUS J, SMIRNOVA IV. Rehabilitation for non-motor symptoms for patients with Parkinson’s disease from an α‑synuclein perspective: a narrative review. Exploration of Neuroprotective Therapy, 2023; 3(4): 235–257.
LIU Y, et al. Clinical characteristics in early Parkinson's disease with excessive daytime sleepiness: a cross-sectional and longitudinal study. Clinical and Translational Science, 2023; 16(11): 2033–2045.
LOPES FG, et al. Prevalência de sintomas não motores em pessoas com doença de Parkinson no Brasil. Revista Neurociências, 2024; 32: 1–20.
MICHAL L, et al. Parkinson's disease and the gastrointestinal microbiome. Journal of Neurology, 2020; 267(9): 3123–3134.
NING F, et al. The effects of non-pharmacological therapies for dysphagia in Parkinson’s disease: a systematic review. Journal of Integrative Neuroscience, 2024; 23(11): 204.
RAHMAN SS, et al. Assessment of the relationship between non-motor features and severity of Parkinson's disease patients in Bangladesh. Mymensingh Medical Journal, 2023; 32(2): 463–475.
SARDAR Z, et al. Non-motor symptoms burden in early stages of Parkinson's disease. Annals of Indian Academy of Neurology, 2023; 26(1): 39–43.
SILVA ABG, et al. Doença de Parkinson: revisão de literatura. Brazilian Journal of Development, 2021; 7(5): 47677–47698.
STORCH A, et al. Flutuações da dor na Doença de Parkinson e sua associação com flutuações motoras e não motoras. Journal of Parkinson’s Disease, 2024; 14(7): 1451–1468.
SUBERT M, et al. Long-term dopaminergic therapy improves spoken language in de-novo Parkinson’s disease. Journal of Neurology, 2025; 272(5): 1-11.
TAN AH, et al. The microbiome‑gut‑brain axis in Parkinson disease—from basic research to the clinic. Nature Reviews Neurology, 2022; 18(8): 509–525.
VAN HOOREN MRA, et al. The effects of surface electrical stimulation plus voice therapy in Parkinson’s disease. Journal of Laryngology and Otology, 2023; 137: 775–781.
WARNECKE T, et al. Gastrointestinal involvement in Parkinson's disease: pathophysiology, diagnosis, and management. npj Parkinson’s Disease, 2022; 8(1): 31.
XU H, et al. Speech and Language Therapy for Voice Problems in Parkinson’s Disease: A Meta-Analysis. Journal of Neuropsychiatry and Clinical Neurosciences, 2020; 32: 344–351.